照護現場(POC)血液凝固檢驗設備的全球市場:產業分析，規模，佔有率，成長，趨勢，預測(2022年～2031年)

本報告提供全球照護現場(POC)血液凝固檢驗設備市場相關調查分析，市場促進因素和阻礙因素，市場機會，COVID-19影響，各市場區隔的分析與預測，各地區分析，企業簡介等資訊。

目錄

第1章 序文

第2章 前提與調查手法

第3章 摘要整理:全球照護現場(POC)血液凝固檢驗設備市場

第4章 市場概要

• 簡介
  • 市場區隔定義
• 概要
• 市場動態
  • 促進因素
  • 阻礙因素
  • 機會
• 全球照護現場(POC)血液凝固檢驗設備市場分析與預測(2017年～2031年)
  • 市場收益預測

第5章 主要洞察

• 技術的進步
• 主要的合併和收購
• COVID-19流行對產業的影響(價值鏈，短、中、長期性的影響)

第6章 全球照護現場(POC)血液凝固檢驗設備市場分析與預測:各產品

• 簡介和定義
• 主要調查結果/開發
• 市場價值預測:各產品(2017年～2031年)
  • 設備、分析設備
  • 消耗品、配件
• 市場魅力分析:各產品

第7章 全球照護現場(POC)血液凝固檢驗設備市場分析與預測:各方法

• 簡介和定義
• 主要調查結果/開發
• 市場價值預測:各方法(2017年～2031年)
  • PT/INR
  • 粘性彈性凝固監測
  • 其他(ACT，aPTT等)
• 市場魅力分析:各方法

第8章 全球照護現場(POC)血液凝固檢驗設備市場分析與預測:各終端用戶

• 簡介和定義
• 主要調查結果/開發
• 市場價值預測:各終端用戶(2017年～2031年)
  • 醫院
  • 診斷研究所
  • 診療所
• 市場魅力分析:各終端用戶

第9章 全球照護現場(POC)血液凝固檢驗設備市場分析與預測:各地區

• 主要調查結果
• 市場價值預測:各地區
  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 中東、非洲
• 市場魅力分析:各地區

第10章 北美的照護現場(POC)血液凝固檢驗設備市場分析與預測

• 簡介
  • 主要調查結果
• 市場價值預測:各產品(2017年～2031年)
  • 設備、分析設備
  • 消耗品、配件
• 市場價值預測:各方法(2017年～2031年)
  • PT/INR
  • 粘性彈性凝固監測
  • 其他(ACT，aPTT等)

第11章 歐洲的照護現場(POC)血液凝固檢驗設備市場分析與預測

第12章 亞太地區的照護現場(POC)血液凝固檢驗設備市場分析與預測

第13章 南美的照護現場(POC)血液凝固檢驗設備市場分析與預測

第14章 中東、非洲的照護現場(POC)血液凝固檢驗設備市場分析與預測

第15章 競爭情形

• 市場參與者 - 競爭矩陣(各階層、企業規模)
• 企業簡介
  • F. Hoffmann-La Roche AG
  • Abbott Laboratories
  • Siemens Healthineers
  • Medtronic plc
  • Haemonetics Corporation
  • HemoSonics, LLC
  • Micropoint Bioscience, Inc.
  • Werfen
  • Sienco, Inc.
  • Koninklijke Philips NV

The report provides revenue of the global point-of-care coagulation testing devices market for the period 2017-2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global point-of-care coagulation testing devices market from 2022 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the point-of-care coagulation testing devices market.

The report delves into the competitive landscape of the global point-of-care coagulation testing devices market. Key players operating in the global point-of-care coagulation testing devices market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global point-of-care coagulation testing devices market profiled in this report.

Table of Contents

1. Preface

• 1.1. Market Definition and Scope
• 1.2. Market Segmentation
• 1.3. Key Research Objectives
• 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Point-of-Care Coagulation Testing Devices Market

4. Market Overview

• 4.1. Introduction
  • 4.1.1. Segment Definition
• 4.2. Overview
• 4.3. Market Dynamics
  • 4.3.1. Drivers
  • 4.3.2. Restraints
  • 4.3.3. Opportunities
• 4.4. Global Point-of-Care Coagulation Testing Devices Market Analysis and Forecast, 2017-2031
  • 4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

• 5.1. Technological Advancements
• 5.2. Key Mergers & Acquisitions
• 5.3. COVID-19 Pandemics Impact on Industry (value chain and short / mid / long term impact)

6. Global Point-of-Care Coagulation Testing Devices Market Analysis and Forecast, by Product

• 6.1. Introduction & Definition
• 6.2. Key Findings / Developments
• 6.3. Market Value Forecast, by Product, 2017-2031
  • 6.3.1. Instruments / Analyzers
  • 6.3.2. Consumables & Accessories
• 6.4. Market Attractiveness Analysis, by Product

7. Global Point-of-Care Coagulation Testing Devices Market Analysis and Forecast, by Method

• 7.1. Introduction & Definition
• 7.2. Key Findings / Developments
• 7.3. Market Value Forecast, by Method, 2017-2031
  • 7.3.1. PT/INR
  • 7.3.2. Viscoelastic Coagulation Monitoring
  • 7.3.3. Others (ACT, aPTT, etc.)
• 7.4. Market Attractiveness Analysis, by Method

8. Global Point-of-Care Coagulation Testing Devices Market Analysis and Forecast, by End-user

• 8.1. Introduction & Definition
• 8.2. Key Findings / Developments
• 8.3. Market Value Forecast, by End-user, 2017-2031
  • 8.3.1. Hospitals
  • 8.3.2. Diagnostic Laboratories
  • 8.3.3. Clinics
• 8.4. Market Attractiveness Analysis, by End-user

9. Global Point-of-Care Coagulation Testing Devices Market Analysis and Forecast, by Region

• 9.1. Key Findings
• 9.2. Market Value Forecast, by Region
  • 9.2.1. North America
  • 9.2.2. Europe
  • 9.2.3. Asia Pacific
  • 9.2.4. Latin America
  • 9.2.5. Middle East & Africa
• 9.3. Market Attractiveness Analysis, by Region

10. North America Point-of-Care Coagulation Testing Devices Market Analysis and Forecast

• 10.1. Introduction
  • 10.1.1. Key Findings
• 10.2. Market Value Forecast, by Product, 2017-2031
  • 10.2.1. Instruments / Analyzers
  • 10.2.2. Consumables & Accessories
• 10.3. Market Value Forecast, by Method, 2017-2031
  • 10.3.1. PT/INR
  • 10.3.2. Viscoelastic Coagulation Monitoring
  • 10.3.3. Others (ACT, aPTT, etc.)

11. Europe Point-of-Care Coagulation Testing Devices Market Analysis and Forecast

• 11.1. Introduction
  • 11.1.1. Key Findings
• 11.2. Market Value Forecast, by Product, 2017-2031
  • 11.2.1. Instruments / Analyzers
  • 11.2.2. Consumables & Accessories
• 11.3. Market Value Forecast, by Method, 2017-2031
  • 11.3.1. PT/INR
  • 11.3.2. Viscoelastic Coagulation Monitoring
  • 11.3.3. Others (ACT, aPTT, etc.)
• 11.4. Market Value Forecast, by End-user, 2017-2031
  • 11.4.1. Hospitals
  • 11.4.2. Diagnostic Laboratories
  • 11.4.3. Clinics
  • 11.4.4. Others
• 11.5. Market Value Forecast, by Country/Sub-region, 2017-2031
  • 11.5.1. Germany
  • 11.5.2. U.K.
  • 11.5.3. France
  • 11.5.4. Spain
  • 11.5.5. Italy
  • 11.5.6. Rest of Europe
• 11.6. Market Attractiveness Analysis
  • 11.6.1. By Product
  • 11.6.2. By Method
  • 11.6.3. By End-user
  • 11.6.4. By Country/Sub-region

12. Asia Pacific Point-of-Care Coagulation Testing Devices Market Analysis and Forecast

• 12.1. Introduction
  • 12.1.1. Key Findings
• 12.2. Market Value Forecast, by Product, 2017-2031
  • 12.2.1. Instruments / Analyzers
  • 12.2.2. Consumables & Accessories
• 12.3. Market Value Forecast, by Method, 2017-2031
  • 12.3.1. PT/INR
  • 12.3.2. Viscoelastic Coagulation Monitoring
  • 12.3.3. Others (ACT, aPTT, etc.)
• 12.4. Market Value Forecast, by End-user, 2017-2031
  • 12.4.1. Hospitals
  • 12.4.2. Diagnostic Laboratories
  • 12.4.3. Clinics
  • 12.4.4. Others
• 12.5. Market Value Forecast, by Country/Sub-region, 2017-2031
  • 12.5.1. China
  • 12.5.2. Japan
  • 12.5.3. India
  • 12.5.4. Australia & New Zealand
  • 12.5.5. Rest of Asia Pacific
• 12.6. Market Attractiveness Analysis
  • 12.6.1. By Product
  • 12.6.2. By Method
  • 12.6.3. By End-user
  • 12.6.4. By Country/Sub-region

13. Latin America Point-of-Care Coagulation Testing Devices Market Analysis and Forecast

• 13.1. Introduction
  • 13.1.1. Key Findings
• 13.2. Market Value Forecast, by Product, 2017-2031
  • 13.2.1. Instruments / Analyzers
  • 13.2.2. Consumables & Accessories
• 13.3. Market Value Forecast, by Method, 2017-2031
  • 13.3.1. PT/INR
  • 13.3.2. Viscoelastic Coagulation Monitoring
  • 13.3.3. Others (ACT, aPTT, etc.)
• 13.4. Market Value Forecast, by End-user, 2017-2031
  • 13.4.1. Hospitals
  • 13.4.2. Diagnostic Laboratories
  • 13.4.3. Clinics
  • 13.4.4. Others
• 13.5. Market Value Forecast, by Country/Sub-region, 2017-2031
  • 13.5.1. Brazil
  • 13.5.2. Mexico
  • 13.5.3. Rest of Latin America
• 13.6. Market Attractiveness Analysis
  • 13.6.1. By Product
  • 13.6.2. By Method
  • 13.6.3. By End-user
  • 13.6.4. By Country/Sub-region

14. Middle East & Africa Point-of-Care Coagulation Testing Devices Market Analysis and Forecast

• 14.1. Introduction
  • 14.1.1. Key Findings
• 14.2. Market Value Forecast, by Product, 2017-2031
  • 14.2.1. Instruments / Analyzers
  • 14.2.2. Consumables & Accessories
• 14.3. Market Value Forecast, by Method, 2017-2031
  • 14.3.1. PT/INR
  • 14.3.2. Viscoelastic Coagulation Monitoring
  • 14.3.3. Others (ACT, aPTT, etc.)
• 14.4. Market Value Forecast, by End-user, 2017-2031
  • 14.4.1. Hospitals
  • 14.4.2. Diagnostic Laboratories
  • 14.4.3. Clinics
  • 14.4.4. Others
• 14.5. Market Value Forecast, by Country/Sub-region, 2017-2031
  • 14.5.1. GCC Countries
  • 14.5.2. South Africa
  • 14.5.3. Rest of Middle East & Africa
• 14.6. Market Attractiveness Analysis
  • 14.6.1. By Product
  • 14.6.2. By Method
  • 14.6.3. By End-user
  • 14.6.4. By Country/Sub-region

15. Competition Landscape

• 15.1. Market Player - Competition Matrix (by tier and size of companies)
• 15.2. Company Profiles
  • 15.2.1. F. Hoffmann-La Roche AG
    • 15.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 15.2.1.2. Product Portfolio
    • 15.2.1.3. SWOT Analysis
    • 15.2.1.4. Strategic Overview
  • 15.2.2. Abbott Laboratories
    • 15.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 15.2.2.2. Product Portfolio
    • 15.2.2.3. Financial Overview
    • 15.2.2.4. SWOT Analysis
    • 15.2.2.5. Strategic Overview
  • 15.2.3. Siemens Healthineers
    • 15.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 15.2.3.2. Product Portfolio
    • 15.2.3.3. SWOT Analysis
    • 15.2.3.4. Strategic Overview
  • 15.2.4. Medtronic plc
    • 15.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 15.2.4.2. Product Portfolio
    • 15.2.4.3. Financial Overview
    • 15.2.4.4. SWOT Analysis
    • 15.2.4.5. Strategic Overview
  • 15.2.5. Haemonetics Corporation
    • 15.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 15.2.5.2. Product Portfolio
    • 15.2.5.3. Financial Overview
    • 15.2.5.4. SWOT Analysis
    • 15.2.5.5. Strategic Overview
  • 15.2.6. HemoSonics, LLC
    • 15.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 15.2.6.2. Product Portfolio
    • 15.2.6.3. SWOT Analysis
    • 15.2.6.4. Strategic Overview
  • 15.2.7. Micropoint Bioscience, Inc.
    • 15.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 15.2.7.2. Product Portfolio
    • 15.2.7.3. Financial Overview
    • 15.2.7.4. SWOT Analysis
    • 15.2.7.5. Strategic Overview
  • 15.2.8. Werfen
    • 15.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 15.2.8.2. Product Portfolio
    • 15.2.8.3. Financial Overview
    • 15.2.8.4. SWOT Analysis
    • 15.2.8.5. Strategic Overview
  • 15.2.9. Sienco, Inc.
    • 15.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 15.2.9.2. Product Portfolio
    • 15.2.9.3. SWOT Analysis
    • 15.2.9.4. Strategic Overview
  • 15.2.10. Koninklijke Philips N.V.
    • 15.2.10.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 15.2.10.2. Product Portfolio
    • 15.2.10.3. SWOT Analysis
    • 15.2.10.4. Strategic Overview

List of Tables

• Table 01: Global Point-of-Care Coagulation Testing Devices Market Value (US$ Mn) Forecast, by Product, 2022-2031
• Table 02: Global Point-of-Care Coagulation Testing Devices Market Value (US$ Mn) Forecast, by Method, 2022-2031
• Table 03: Global Point-of-Care Coagulation Testing Devices Market Value (US$ Mn) Forecast, by End-user, 2022-2031
• Table 04: Global Point-of-Care Coagulation Testing Devices Market Value (US$ Mn) Forecast, by Region, 2022-2031
• Table 05: North America Point-of-Care Coagulation Testing Devices Market Value (US$ Mn) Forecast, by Product, 2022-2031
• Table 06: North America Point-of-Care Coagulation Testing Devices Market Value (US$ Mn) Forecast, by Method, 2022-2031
• Table 07: North America Point-of-Care Coagulation Testing Devices Market Value (US$ Mn) Forecast, by End-user, 2022-2031
• Table 08: North America Point-of-Care Coagulation Testing Devices Market Value (US$ Mn) Forecast, by Country, 2022-2031
• Table 09: Europe Point-of-Care Coagulation Testing Devices Market Value (US$ Mn) Forecast, by Product, 2022-2031
• Table 10: Europe Point-of-Care Coagulation Testing Devices Market Value (US$ Mn) Forecast, by Method, 2022-2031
• Table 11: Europe Point-of-Care Coagulation Testing Devices Market Value (US$ Mn) Forecast, by End-user, 2022-2031
• Table 12: Europe Point-of-Care Coagulation Testing Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2022-2031
• Table 13: Asia Pacific Point-of-Care Coagulation Testing Devices Market Value (US$ Mn) Forecast, by Product
• Table 14: Asia Pacific Point-of-Care Coagulation Testing Devices Market Value (US$ Mn) Forecast, by Method
• Table 15: Asia Pacific Point-of-Care Coagulation Testing Devices Market Value (US$ Mn) Forecast, by End-user
• Table 16 Asia Pacific Point-of-Care Coagulation Testing Devices Market Value (US$ Mn) Forecast, by Country/Sub-region
• Table 17: Latin America Point-of-Care Coagulation Testing Devices Market Value (US$ Mn) Forecast, by Product
• Table 18: Latin America Point-of-Care Coagulation Testing Devices Market Value (US$ Mn) Forecast, by Method, 2022-2031
• Table 19: Latin America Point-of-Care Coagulation Testing Devices Market Value (US$ Mn) Forecast, by End-user, 2022-2031
• Table 20: Latin America Point-of-Care Coagulation Testing Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2022-2031
• Table 21: Middle East & Africa Point-of-Care Coagulation Testing Devices Market Value (US$ Mn) Forecast, by Product, 2022-2031
• Table 22: Middle East & Africa Point-of-Care Coagulation Testing Devices Market Value (US$ Mn) Forecast, by Method, 2022-2031
• Table 23: Middle East & Africa Point-of-Care Coagulation Testing Devices Market Value (US$ Mn) Forecast, by End-user, 2022-2031
• Table 24: Middle East & Africa Point-of-Care Coagulation Testing Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2022-2031

List of Figures

• Figure 01: Global Point-of-Care Coagulation Testing Devices Market Size (US$ Mn) Forecast 2022-2031
• Figure 02: Global Point-of-Care Coagulation Testing Devices Market Value Share, by Method, 2022
• Figure 03: Global Point-of-Care Coagulation Testing Devices Market Value Share, by Product, 2022
• Figure 04: Global Point-of-Care Coagulation Testing Devices Market Value Share, by End-user, 2022
• Figure 05: Global Point-of-Care Coagulation Testing Devices Market Value Share, by Region, 2022
• Figure 06: Global Point-of-Care Coagulation Testing Devices Market Value Share Analysis, by Product, 2021 and 2031
• Figure 07: Global Point-of-Care Coagulation Testing Devices Market Attractiveness Analysis, by Product, 2022-2031
• Figure 08: Global Point-of-Care Coagulation Testing Devices Market Revenue (US$ Mn) by Instruments/Analyzers, 2022-2031
• Figure 09: Global Point-of-Care Coagulation Testing Devices Market Revenue (US$ Mn) by Consumables & Accessories, 2022-2031
• Figure 10: Global Point-of-Care Coagulation Testing Devices Market Value Share Analysis, by Method, 2021 and 2031
• Figure 11: Global Point-of-Care Coagulation Testing Devices Market Attractiveness Analysis, by Method, 2022-2031
• Figure 12: Global Point-of-Care Coagulation Testing Devices Market Revenue (US$ Mn) Forecast, by PT/INR, 2022-2031
• Figure 13: Global Point-of-Care Coagulation Testing Devices Market Revenue (US$ Mn) Forecast, by Others, 2022-2031
• Figure 14: Global Point-of-Care Coagulation Testing Devices Market Revenue (US$ Mn) Forecast, by Viscoelastic Coagulation Monitoring, 2022-2031
• Figure 15: Global Point-of-Care Coagulation Testing Devices Market Value Share Analysis, by End-user, 2021 and 2031
• Figure 16: Global Point-of-Care Coagulation Testing Devices Market Attractiveness Analysis, by End-user, 2022-2031
• Figure 17: Global Point-of-Care Coagulation Testing Devices Market Revenue (US$ Mn) by Hospitals, 2022-2031
• Figure 18: Global Point-of-Care Coagulation Testing Devices Market Revenue (US$ Mn) by Diagnostic Laboratories, 2022-2031
• Figure 19: Global Point-of-Care Coagulation Testing Devices Market Revenue (US$ Mn) by Clinics, 2022-2031
• Figure 20: Global Point-of-Care Coagulation Testing Devices Market Revenue (US$ Mn) by Other End-users, 2022-2031
• Figure 21: Global Point-of-Care Coagulation Testing Devices Market Value Share, by Region, 2021 and 2031
• Figure 22: Global Point-of-Care Coagulation Testing Devices Market Attractiveness Analysis, by Region, 2022-2031
• Figure 23: North America Point-of-Care Coagulation Testing Devices Market Value (US$ Mn) Forecast 2022-2031
• Figure 24: North America Point-of-Care Coagulation Testing Devices Market Value Share Analysis, by Product, 2021 and 2031
• Figure 25: North America Point-of-Care Coagulation Testing Devices Market Attractiveness Analysis, by Product, 2022-2031
• Figure 26: North America Point-of-Care Coagulation Testing Devices Market Value Share Analysis, by Method, 2021 and 2031
• Figure 27: North America Point-of-Care Coagulation Testing Devices Market Attractiveness Analysis, by Method, 2022-2031
• Figure 28: North America Point-of-Care Coagulation Testing Devices Market Value Share Analysis, by End-user, 2021 and 2031
• Figure 29: North America Point-of-Care Coagulation Testing Devices Market Attractiveness Analysis, by End-user, 2022-2031
• Figure 30: North America Point-of-Care Coagulation Testing Devices Market Value Share Analysis, by Country, 2021 and 2031
• Figure 31: North America Point-of-Care Coagulation Testing Devices Market Attractiveness Analysis, by Country, 2022-2031
• Figure 32: Europe Point-of-Care Coagulation Testing Devices Market Value (US$ Mn) Forecast 2022-2031
• Figure 33: Europe Point-of-Care Coagulation Testing Devices Market Value Share Analysis, by Product, 2021 and 2031
• Figure 34: Europe Point-of-Care Coagulation Testing Devices Market Attractiveness Analysis, by Product, 2022-2031
• Figure 35: Europe Point-of-Care Coagulation Testing Devices Market Value Share Analysis, by Method, 2021 and 2031
• Figure 36: Europe Point-of-Care Coagulation Testing Devices Market Attractiveness Analysis, by Method, 2022-2031
• Figure 37: Europe Point-of-Care Coagulation Testing Devices Market Value Share Analysis, by End-user, 2021 and 2031
• Figure 38: Europe Point-of-Care Coagulation Testing Devices Market Attractiveness Analysis, by End-user, 2022-2031
• Figure 39: Europe Point-of-Care Coagulation Testing Devices Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
• Figure 40: Europe Point-of-Care Coagulation Testing Devices Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
• Figure 41: Asia Pacific Point-of-Care Coagulation Testing Devices Market Value (US$ Mn) Forecast 2022-2031
• Figure 42: Asia Pacific Point-of-Care Coagulation Testing Devices Market Value Share Analysis, by Product, 2021 and 2031
• Figure 43: Asia Pacific Point-of-Care Coagulation Testing Devices Market Attractiveness Analysis, by Product, 2022-2031
• Figure 44: Asia Pacific Point-of-Care Coagulation Testing Devices Market Value Share Analysis, by Method, 2021 and 2031
• Figure 45: Asia Pacific Point-of-Care Coagulation Testing Devices Market Attractiveness Analysis, by Method, 2022-2031
• Figure 46: Asia Pacific Point-of-Care Coagulation Testing Devices Market Value Share Analysis, by End-user, 2021 and 2031
• Figure 47: Asia Pacific Point-of-Care Coagulation Testing Devices Market Attractiveness Analysis, by End-user, 2022-2031
• Figure 48: Asia Pacific Point-of-Care Coagulation Testing Devices Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
• Figure 49: Asia Pacific Point-of-Care Coagulation Testing Devices Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
• Figure 50: Latin America Point-of-Care Coagulation Testing Devices Market Value (US$ Mn) Forecast 2022-2031
• Figure 51: Latin America Point-of-Care Coagulation Testing Devices Market Value Share Analysis, by Product, 2021 and 2031
• Figure 52: Latin America Point-of-Care Coagulation Testing Devices Market Attractiveness Analysis, by Product, 2022-2031
• Figure 53: Latin America Point-of-Care Coagulation Testing Devices Market Value Share Analysis, by Method, 2021 and 2031
• Figure 54: Latin America Point-of-Care Coagulation Testing Devices Market Attractiveness Analysis, by Method, 2022-2031
• Figure 55: Latin America Point-of-Care Coagulation Testing Devices Market Value Share Analysis, by End-user, 2021 and 2031
• Figure 56: Latin America Point-of-Care Coagulation Testing Devices Market Attractiveness Analysis, by End-user, 2022-2031
• Figure 57: Latin America Point-of-Care Coagulation Testing Devices Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
• Figure 58: Latin America Point-of-Care Coagulation Testing Devices Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
• Figure 59: Middle East & Africa Point-of-Care Coagulation Testing Devices Market Value (US$ Mn) Forecast 2022-2031
• Figure 60: Middle East & Africa Point-of-Care Coagulation Testing Devices Market Value Share Analysis, by Product, 2021 and 2031
• Figure 61: Middle East & Africa Point-of-Care Coagulation Testing Devices Market Attractiveness Analysis, by Product, 2022-2031
• Figure 62: Middle East & Africa Point-of-Care Coagulation Testing Devices Market Value Share Analysis, by Method, 2021 and 2031
• Figure 63: Middle East & Africa Point-of-Care Coagulation Testing Devices Market Attractiveness Analysis, by Method, 2022-2031
• Figure 64: Middle East & Africa Point-of-Care Coagulation Testing Devices Market Value Share Analysis, by End-user, 2021 and 2031
• Figure 65: Middle East & Africa Point-of-Care Coagulation Testing Devices Market Attractiveness Analysis, by End-user, 2022-2031
• Figure 66: Middle East & Africa Point-of-Care Coagulation Testing Devices Market Value Share Analysis, by Country/Sub-region
• Figure 67: Middle East & Africa Point-of-Care Coagulation Testing Devices Market Attractiveness Analysis, by Country/Sub-region
• Figure 68: Global Point-of-Care Coagulation Testing Devices Market Analysis, by Top Company Ranking, 2022
• Figure 69: F. Hoffmann-La Roche AG Revenue (US$ Bn)
• Figure 70: F. Hoffmann-La Roche AG R&D Expenses
• Figure 71: F. Hoffmann-La Roche AG Breakdown of Net Sales, by Business Division
• Figure 72: F. Hoffmann-La Roche AG Breakdown of Net Sales, by Country/Region
• Figure 73: Abbott Laboratories Revenue (US$ Bn)
• Figure 74: Abbott Laboratories R&D Intensity and Sales & Marketing (%),
• Figure 75: Abbott Laboratories Breakdown of Net Sales, by Business Division
• Figure 76: Abbott Laboratories Breakdown of Net Sales, by Country/Region
• Figure 77: Abbott Laboratories Revenue (US$ Mn)
• Figure 78: Abbott Laboratories R&D Expenses (US$ Mn)
• Figure 79: Abbott Laboratories Breakdown of Net Sales, by Business Division
• Figure 80: Abbott Laboratories Breakdown of Net Sales, by Country/Region
• Figure 81: Medtronic plc Revenue (US$ Mn)
• Figure 82: Medtronic plc Breakdown of Net Sales (%), by Region
• Figure 83: Medtronic plc R&D Expenditure (US$ Mn)
• Figure 84: Medtronic plc Breakdown of Net Sales (%), by Business Segment
• Figure 85: Haemonetics Corporation Revenue (US$ Mn)
• Figure 86: Haemonetics Corporation R&D Expenses (US$ Mn)
• Figure 87: Haemonetics Corporation Net Sales Breakdown (%), by Region
• Figure 88: Haemonetics Corporation Net Sales Breakdown (%), by Business Segment
• Figure 89: Werfen Revenue (US$ Mn)
• Figure 90: Werfen Breakdown of Net Sales (%), by Region
• Figure 91: Werfen Breakdown of Net Sales (%), by Business Segment
• Figure 92: Koninklijke Philips N.V. Revenue (US$ Mn)
• Figure 93: Koninklijke Philips N.V. Breakdown of Net Sales (%), by Region
• Figure 94: Koninklijke Philips N.V. R&D Expenditure (US$ Mn)
• Figure 95: Koninklijke Philips N.V. Breakdown of Net Sales (%), by Business Segment